MatthewDavidRingelMD
Endocrinology • Columbus, OHDiabetes, Lipid Metabolism, Thyroid
Professor, Internal Medicine, Ohio State University College of Medicine
Dr. Ringel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
410 W 10th Ave
Columbus, OH 43210Phone+1 614-293-8000- Is this information wrong?
Education & Training
Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1994 - 1997
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1991 - 1994
Pennsylvania State University College of MedicineClass of 1991
Certifications & Licensure
OH State Medical License 2003 - 2026
DC State Medical License 1997 - 2004
VA State Medical License 1993 - 2000- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 1 citationsCombined Vorinostat and Chloroquine Inhibit Sodium-Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo.Martin L Read, Katie Brookes, Ling Zha, Selvambigai Manivannan, Jana Kim, Merve Kocbiyik, Alice Fletcher, Caroline M Gorvin, George Firth, Gilbert O Fruhwirth, Juan P ...> ;Clinical Cancer Research. 2024 Apr 1
- Presumed Pathogenic Germ Line and Somatic Variants in African American Thyroid Cancer.Zachary A Hurst, Sandya Liyanarachchi, Pamela Brock, Huiling He, Fadi Nabhan, Colleen Veloski, Amanda E Toland, Matthew D Ringel, Sissy M Jhiang> ;Thyroid. 2024 Mar 1
- Indolent behavior of malignant Bethesda III nodules compared to Bethesda V/VI nodules.Peng, J., Brock, P., Endo, M., Nabhan, F., Azaryan, I., Long, C., Ryan, L., Ringel, M., Sipos, J.> ;The Journal of Clinical Endocrinology and Metabolism. 2024 Feb 28
- Join now to see all
Press Mentions
Could Blockbuster Weight Loss Drugs Also Be Used to Treat Heart Disease, Alzheimer’s, and Cancer?January 11th, 2024
Grant Support
- RCAN1 In Thyroid Cancer ProgressionNational Cancer Institute2011–2012
- P21 Activated Kinases And EMT In Thyroid CancerNational Cancer Institute2008–2012
- Genetic And Signaling Pathways In Epithelial Thyroid CancerNational Cancer Institute2008–2012
- Administration And BudgetingNational Cancer Institute2008–2012
- AKT Intracellular Localization In Thyroid CancerNational Cancer Institute2005–2009
- Anti-Metastatic Effect Of MCIP1 In Thyroid CancerNational Cancer Institute2005–2006
Professional Memberships
- Member
Hospital Affiliations
The OSUCCC - JamesColumbus, Ohio
Ohio State University Wexner Medical CenterColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
